Terms: = Breast cancer AND FH, HLRCC, 2271, ENSG00000091483, MCUL1, MCL, LRCC, P07954
556 results:
1. Causal association between complement system FHR-5, CTRP9, and breast carcinoma in situ: a Mendelian randomization study.
Peng YL; Li H; Sun P; Zhang HD; Li D; Wang HB; Zhang L
Eur Rev Med Pharmacol Sci; 2024 Mar; 28(6):2363-2371. PubMed ID: 38567599
[TBL] [Abstract] [Full Text] [Related]
2. The influence of marital status at diagnosis on survival of adult patients with mantle cell lymphoma.
Zhang T; Wang ZT; Li Z; Yin SX; Wang X; Chen HZ
J Cancer Res Clin Oncol; 2024 Mar; 150(3):120. PubMed ID: 38466431
[TBL] [Abstract] [Full Text] [Related]
3. Antiproliferative activities of some selected Nigerian medicinal plants against breast, liver, and cervical cancer cells.
Olaleye OO; Kim DH; Spriggs KA
BMC Complement Med Ther; 2024 Mar; 24(1):110. PubMed ID: 38448883
[TBL] [Abstract] [Full Text] [Related]
4. A cost-benefit analysis of genetic screening test for breast cancer in Iran.
Meshkani Z; Moradi N; Aboutorabi A; Farabi H; Moini N
BMC Cancer; 2024 Mar; 24(1):279. PubMed ID: 38429685
[TBL] [Abstract] [Full Text] [Related]
5. Characterization of BCL-X L , mcl-1, and BAX Protein Expression in Response to Neoadjuvant Chemotherapy in breast cancer.
Saleh T; Al Shboul S; Awad H; El-Sadoni M; Alhesa A; Alsharaiah E; Abu Shahin N; Alotaibi MR; Battah A; Azab B
Appl Immunohistochem Mol Morphol; 2024 Apr; 32(4):189-199. PubMed ID: 38426376
[TBL] [Abstract] [Full Text] [Related]
6. Comprehensive Inherited Risk Estimation for Risk-Based breast cancer Screening in Women.
Mars N; Kerminen S; Tamlander M; Pirinen M; Jakkula E; Aaltonen K; Meretoja T; Heinävaara S; Widén E; Ripatti S;
J Clin Oncol; 2024 May; 42(13):1477-1487. PubMed ID: 38422475
[TBL] [Abstract] [Full Text] [Related]
7. Sacituzumab govitecan plus platinum-based chemotherapy mediates significant antitumor effects in triple-negative breast, urinary bladder, and small-cell lung carcinomas.
Cardillo TM; Zalath MB; Arrojo R; Sharkey RM; Govindan SV; Chang CH; Goldenberg DM
Oncotarget; 2024 Feb; 15():144-158. PubMed ID: 38386805
[TBL] [Abstract] [Full Text] [Related]
8. Structural optimization of siRNA conjugates for albumin binding achieves effective mcl1-directed cancer therapy.
Hoogenboezem EN; Patel SS; Lo JH; Cavnar AB; Babb LM; Francini N; Gbur EF; Patil P; Colazo JM; Michell DL; Sanchez VM; McCune JT; Ma J; DeJulius CR; Lee LH; Rosch JC; Allen RM; Stokes LD; Hill JL; Vickers KC; Cook RS; Duvall CL
Nat Commun; 2024 Feb; 15(1):1581. PubMed ID: 38383524
[TBL] [Abstract] [Full Text] [Related]
9. The clinicopathologic and molecular features, and treatment outcome of fumarate hydratase-deficient renal cell carcinoma: a retrospective comparison with type 2 papillary renal cell carcinoma.
Bai J; Li X; Wen Y; Lu Q; Chen R; Liu R; Shangguan T; Ye Y; Lin J; Cai W; Kang D; Chen J
Aging (Albany NY); 2024 Feb; 16(4):3631-3646. PubMed ID: 38376408
[TBL] [Abstract] [Full Text] [Related]
10. The Proteomic Analysis of cancer-Related Alterations in the Human Unfoldome.
Paromov V; Uversky VN; Cooley A; Liburd LE; Mukherjee S; Na I; Dayhoff GW; Pratap S
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338831
[TBL] [Abstract] [Full Text] [Related]
11. Phase I study of bendamustine, rituximab, ibrutinib, and venetoclax in relapsed, refractory mantle cell lymphoma.
Grieve C; Joseph A; Drullinsky P; Zelenetz AD; Hamlin P; Kumar A
Leuk Lymphoma; 2024 Feb; 65(2):235-241. PubMed ID: 38264906
[TBL] [Abstract] [Full Text] [Related]
12. Prediction of sentinel lymph node metastasis in breast cancer patients based on preoperative features: a deep machine learning approach.
Shahriarirad R; Meshkati Yazd SM; Fathian R; Fallahi M; Ghadiani Z; Nafissi N
Sci Rep; 2024 Jan; 14(1):1351. PubMed ID: 38228684
[TBL] [Abstract] [Full Text] [Related]
13. Revisiting Screening in Women With a Family History of breast cancer.
Coffey K; Mango V
J Breast Imaging; 2023 Nov; 5(6):635-645. PubMed ID: 38141237
[TBL] [Abstract] [Full Text] [Related]
14. Secondary (additional) findings from the 100,000 Genomes Project: Disease manifestation, health care outcomes, and costs of disclosure.
Nolan J; Buchanan J; Taylor J; Almeida J; Bedenham T; Blair E; Broadgate S; Butler S; Cazeaux A; Craft J; Cranston T; Crawford G; Forrest J; Gabriel J; George E; Gillen D; Haeger A; Hastings Ward J; Hawkes L; Hodgkiss C; Hoffman J; Jones A; Karpe F; Kasperaviciute D; Kovacs E; Leigh S; Limb E; Lloyd-Jani A; Lopez J; Lucassen A; McFarlane C; O'Rourke AW; Pond E; Sherman C; Stewart H; Thomas E; Thomas S; Thomas T; Thomson K; Wakelin H; Walker S; Watson M; Williams E; Ormondroyd E
Genet Med; 2024 Mar; 26(3):101051. PubMed ID: 38131308
[TBL] [Abstract] [Full Text] [Related]
15. Clinical implications of incorporating genetic and non-genetic risk factors in CanRisk-based breast cancer risk prediction.
Tüchler A; De Pauw A; Ernst C; Anota A; Lakeman IMM; Dick J; van der Stoep N; van Asperen CJ; Maringa M; Herold N; Blümcke B; Remy R; Westerhoff A; Stommel-Jenner DJ; Frouin E; Richters L; Golmard L; Kütting N; Colas C; Wappenschmidt B; Rhiem K; Devilee P; Stoppa-Lyonnet D; Schmutzler RK; Hahnen E
Breast; 2024 Feb; 73():103615. PubMed ID: 38061307
[TBL] [Abstract] [Full Text] [Related]
16. Unawareness of breast cancer family history among African women.
Adedokun B; Ademola A; Makumbi T; Odedina S; Agwai I; Ndom P; Gakwaya A; Ogundiran T; Ojengbede O; Huo D; Olopade OI
Pan Afr Med J; 2023; 45():188. PubMed ID: 38020349
[TBL] [Abstract] [Full Text] [Related]
17. Tumor heterogeneity and immune-evasive T follicular cell lymphoma phenotypes at single-cell resolution.
Suma S; Suehara Y; Fujisawa M; Abe Y; Hattori K; Makishima K; Sakamoto T; Sawa A; Bando H; Kaji D; Sugio T; Kato K; Akashi K; Matsue K; Carreras J; Nakamura N; Suzuki A; Suzuki Y; Ito K; Shiiba H; Chiba S; Sakata-Yanagimoto M
Leukemia; 2024 Feb; 38(2):340-350. PubMed ID: 38012392
[TBL] [Abstract] [Full Text] [Related]
18. Oncolytic Activity of Canine Distemper Virus in Human Ductal breast Carcinoma Cells.
Jhala D; Nathani N; Joshi M; Patel A; Joshi CG
Oncol Res Treat; 2024; 47(1-2):10-17. PubMed ID: 38008084
[TBL] [Abstract] [Full Text] [Related]
19. Rate of Pathogenic Germline Variants in Patients With Lung cancer.
Sorscher S; LoPiccolo J; Heald B; Chen E; Bristow SL; Michalski ST; Nielsen SM; Lacoste A; Keyder E; Lee H; Nussbaum RL; Martins R; Esplin ED
JCO Precis Oncol; 2023 Sep; 7():e2300190. PubMed ID: 37992258
[TBL] [Abstract] [Full Text] [Related]
20. Awareness and Candidacy for Endocrine Prevention and Risk Reducing Mastectomy in Unaffected High-Risk Women Referred for breast cancer Risk Assessment.
Alhassan B; Rjeily MB; Villareal-Corpuz V; Prakash I; Basik M; Boileau JF; Martel K; Pollak M; Foulkes WD; Wong SM
Ann Surg Oncol; 2024 Feb; 31(2):981-987. PubMed ID: 37973648
[TBL] [Abstract] [Full Text] [Related]
[Next]
